Cargando…
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration
Myeloma (MM) cells and osteoclasts are mutually interacted to enhance MM growth while creating acidic bone lesions. Here, we explored acid sensing of MM cells and its role in MM cell response to acidic conditions. Acidic conditions activated the PI3K-Akt signaling in MM cells while upregulating the...
Autores principales: | Amachi, Ryota, Hiasa, Masahiro, Teramachi, Jumpei, Harada, Takeshi, Oda, Asuka, Nakamura, Shingen, Hanson, Derek, Watanabe, Keiichiro, Fujii, Shiro, Miki, Hirokazu, Kagawa, Kumiko, Iwasa, Masami, Endo, Itsuro, Kondo, Takeshi, Yoshida, Sumiko, Aihara, Ken-Ichi, Kurahashi, Kiyoe, Kuroda, Yoshiaki, Horikawa, Hideaki, Tanaka, Eiji, Matsumoto, Toshio, Abe, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342564/ https://www.ncbi.nlm.nih.gov/pubmed/27626482 http://dx.doi.org/10.18632/oncotarget.11927 |
Ejemplares similares
-
Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
por: Bat-Erdene, Ariunzaya, et al.
Publicado: (2016) -
Effective impairment of myeloma cells and their progenitors by hyperthermia
por: Miki, Hirokazu, et al.
Publicado: (2017) -
Myeloma–Bone Interaction: A Vicious Cycle via TAK1–PIM2 Signaling
por: Harada, Takeshi, et al.
Publicado: (2021) -
TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma
por: Teramachi, Jumpei, et al.
Publicado: (2020) -
Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation
por: Hanson, Derek James, et al.
Publicado: (2015)